Seasoned pharmaceutical executive with extensive experience in high-growth life sciences companies joins NervGenLeadership appointment supports the company's mission to advance…
New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL /…
NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Omni-Biotic US is proud to announce that Omni-Biotic AB 10…
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany…
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a New York, USA-based company researching stem cells in…
Over $7.3 million raised this year alone for Albertans facing cancer in Alberta’s largest cycling fundraiserSTRATHMORE, Alberta, July 20, 2024…
BEIJING, July 19, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and…
AUSTIN, TX / ACCESSWIRE / July 19, 2024 / Medicare officially announces LCD changes that expand access to microprocessor-controlled knees…
July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals…
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical…